Skip to Main Content

Paper Details

Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer.
Clin Cancer Res
12
2020
AVPC, Aggressive variant prostate cancer, CD133, CD133-expressing tumors, CD133-negative, CD133-positive tumors, CD133-targeted IgG, HA10 IgG, Lethal Prostate Cancer, [89Zr]Zr, androgen, androgen receptor, men, metastatic lesions, patient, prostate cancer, transmembrane protein CD133
Author NameAffiliation
Ilsa ColemanFred Hutchinson Cancer Research Center
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonFred Hutchinson Cancer Research Center
  • 1 - 3

Datasets

Release 1.2